发明名称 Glutathione-based drug delivery system
摘要 Disclosed is a conjugate comprising: a) a ligand for a glutathione transporter; and, b) a pharmaceutically acceptable nanocontainer containing a steroidal agent, wherein the nanocontainer is a nanocontainer selected from the group consisting of: A. a carrier protein; B. a liposome; C. a polyplex system; D. a lipoplex system; and E. polyethyleneglycol; and the ligand in a) is conjugated to at least one of the steroidal agent and the nanocontainer in b). Examples of a suitable a ligand for a glutathione transporter are glutathione, S-(p-bromobenzyl)glutathione, gamma-(L-gamma- azaglutamyl)-S-(p-bromobenzyl)-L-cysteinylglycin, S-butylglutathione, S-decylglutathione, glutathione reduced ethyl ester, glutathionesulfonic acid, S-hexylglutathione, S-lactoylglutathione, S-methylglutathione, S-(4-nitrobenzyl) glutathione, S-octylglutathione, S-propylglutathione, n-butanoyl gamma-glutamylcysteinylglycine, ethanoyl gamma-glutamylcysteinylglycine, hexanoyl gamma-glutamylcysteinylglycine, octanoyl gamma-glutamylcysteinylglycine, dodecanoyl gamma-glutamylcysteinylglycine, GSH monoisopropyl ester (N-(N-L-glutamyl-L-cysteinyl)glycine 1-isopropyl ester sulfate monohydrate) and glutathione derivatives.
申请公布号 NZ616673(A) 申请公布日期 2014.08.29
申请号 NZ20100616673 申请日期 2010.02.19
申请人 TO-BBB HOLDING B.V. 发明人 GAILLARD PIETER JAAP
分类号 A61K47/48;A61K49/00;A61P25/28;A61P31/12;A61P35/00 主分类号 A61K47/48
代理机构 代理人
主权项
地址